Hyperthyroidism and hypothyroidism are immune-mediated adverse events, and the pooled ORs showed that the risk of these two AEs was significantly higher in the anti-PD-1/PD-L1 groups (Table 4, Supplementary Figures). The gene discussed is CD274; the disease is hyperthyroidism.